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Dairy cattle are a primary reservoir of Coxiella burnetii,
which causes Q fever. However, no recent nationwide stud-
ies have assessed the prevalence and risks of Q fever in
dairy cattle. We report >94% prevalence in samples of bulk
tank milk from U.S. dairy herds tested during the past 3
years. 
Q
fever is a ubiquitous zoonosis caused by Coxiella
burnetii, an obligate intracellular rickettsial organ-
ism. Since the first independent reports by Australian and
American investigators in 1935, Q fever has been found
throughout the world, except New Zealand (1). C. burnetii
infections have been reported in humans, farm animals, pet
animals, wild animals, and arthropods (2). Among farm
animals, dairy cattle, sheep, and goats are the major reser-
voirs of C. burnetii. Animals are often naturally infected
but usually do not show typical symptoms of C. burnetii
infection. Clinical signs of C. burnetii infection are abor-
tion in sheep and goats and reproductive disorders in cattle
(1,3). C. burnetii can be isolated from the blood, lungs,
spleen, and liver of infected animals in the acute phase of
the disease. The uterus and mammary glands are primary
sites of infection in the chronic phase of C. burnetii.
Shedding ofC. burnetii into the environment occurs main-
ly during parturition by birth products,particularly the pla-
centa of sheep. Also, shedding of C. burnetii in milk by
infected dairy cattle is well documented (1,3). 
Previous studies on the prevalence of C. burnetii in
dairy cattle were based mainly on serologic tests, including
complement fixation, indirect immunofluorescent assay
(IFA), and enzyme-linked immunosorbent assay (ELISA).
However, the seroprevalence of C. burnetii infection in
cattle varies widely from 1 country to another and from 1
state to another in the United States. In Japan, a prevalence
of 1.1% to 3.9% of C. burnetii infection in cattle was
reported in the 1950s. However, a 1992 survey reported
that 29.5% of healthy cattle and 84.3% of cattle with repro-
ductive disorders in Japan had antibodies to C. burnetii
shown by using IFA (4). In Canada, 67% of the 200 dairy
herds were ELISA-positive for antibodies to C. burnetii
(5). The reported seroprevalence of Q fever in the United
States varies from 1% to 73%. Reports from the same state
show wide differences depending on testing methods and
the year of surveys; for example, the seroprevalence in
Wisconsin was 33% in 1957 but 73% in 1962 (6).
Seroepidemiologic studies have indicated that C. burnetii
antibody seroprevalence in cattle has increased from the
prevalence 20 or 30 years ago (7). However, the real
prevalence of C. burnetii infection in cattle is not avail-
able, due in part to the lack of surveillance (8). Shedding
of C. burnetii in milk by infected cattle was shown in stud-
ies conducted during the 1940s and 1950s. 
Isolation of the Q fever agent by laboratory workers is
difficult because the agent has a high infectivity rate, it is
cumbersome in in vitro culture conditions, and handling it
requires rigorous compliance requirements. Q fever is con-
sidered a “select agent” because it can potentially be used
in bioterrorism and its handling is federally regulated.
Recently, polymerase chain reaction (PCR) assays have
been used to detect C. burnetii (9). Atrans-PCR assay was
implemented to detect C. burnetii in milk by targeting a
transposon-like sequence found only in C. burnetii (10).
The trans-PCR assay detects C. burnetii in samples imme-
diately, unlike serologic assays that detect antibodies that
could have been introduced months earlier.
A real-time PCR assay targeting IS1111 was developed
in this study to measure amounts of C. burnetii shed in
milk. Our study was to assess the prevalence of C. burnetii
in bulk milk samples from dairy herds in the United States
by using PCR. 
The Study
The samples in this study were somatic cells extracted
from bulk tank milk aliquots submitted to the New York
State Animal Health Diagnostic Laboratory to detect
bovine viral diarrhea that persistently infected lactating
dairy cattle. The samples tested do not represent a random
sampling, as tests were done only on samples available.
The samples are heavily weighted to the Northeast, but
some are from the Midwest and West. We tested 316 bulk
tank milk samples from dairy herds in the United States
during a 3-year period from January 2001 to December
2003 by using trans-PCR (Figure). Positive results were
confirmed by nested PCR and DNA sequencing. The
sequencing results of the 687-bp PCR product were consis-
tent with the published sequence of IS1111 with 100%
homology. A summary of the PCR test results of the bulk
tank samples is shown in Table 1. The overall prevalence
of C. burnetii in the tested samples was 94.3% with little
variation (93.2% to 94.7%) from year to year. Samples
from New York State did not show significant variation
from other states, which indicates that C. burnetii infection
in the dairy herds was persistent or steady, with little tem-
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times from 2002 to 2004 from specific cattle in a small, C.
burnetii–positive dairy to monitor the infection in specific
cattle. A summary of the results of tests on milk samples
from specific cattle is presented in Table 2. While 28
(52.8%) of 53 cattle were C. burnetii positive in 2002,
23.5% and 31.3% of the cattle were positive in 2003 and
2004, respectively. Daily and weekly shedding levels of 5
C. burnetii– positive cattle were assayed by real-time PCR.
Real-time PCR was conducted by using the primers and
probe designed by the Primer Express program (Applied
Biosystems, Foster City, CA). The primer set consisted of
primers trans-f (5′-GGGTAAAACGGTGGAACA ACA-
3′) and trans-r (5′-ACAACCCCCGAATCTCATTG-3′).
The internal probe trans-p (5′-AACGATCGCGTATCTT-
TAACAGCGCTTG-3′) was labeled with the reporter dye
5-carboxyfluoroscein (FAM) on the 5′  end and the
quencher dye N′, N′, N′, N′-tetramethyl-6-carboxyrho-
damine (TAMRA) at the 3′ end. The reactions and assay
conditions were according to the manufacturer’s instruc-
tions (Applied Biosystems). Each cattle shed a similar
amount of C. burnetii daily over 7 days; weekly shedding
over 4 weeks was also similar. Shedding levels of positive
cattle were estimated to be 101–104 cells/mL each. The
bulk tank milk samples of the herd stayed at a level of 102
cells/mL over 3 years.
Conclusions
Bulk tank milk has been used for surveillance samples
in dairy herds for several bovine diseases including bovine
viral diarrhea. More than 90% of U.S. dairy herds sampled
were infected with C. burnetii based on bulk tank milk
testing over a 3-year period. This high prevalence did not
show temporal or regional variation, suggesting that C.
burnetii infections in dairy herds are common throughout
the United States. Our report of C. burnetii in dairy herds
is not surprising if earlier reports regarding an increase of
bovine infection in North America are considered. An
early investigator concluded that C. burnetii was endemic
throughout the United States in the 1950s and predicted
that a high bovine infection rate could occur in other parts
of the country, as it did in southern California where a 98%
infection rate was reported (11). A California survey
reported that 20 (100%) of 20 herds in 17 counties
throughout the state contained seropositive cattle, and 82%
of 1,052 specific cattle from the herds were seropositive
(12). An increase in the prevalence of Q fever from 2.3%
in 1964 to 66.8% in 1984 was reported in Ontario dairy
herds (13). Our study found a notable decrease in shedding
of C. burnetii in milk by specific cattle from 52.8% to
23.5% over 3 years (Table 2). This decrease was not
because animals stopped shedding the organism but
because uninfected animals replaced shedding animals
with an average annual replacement rate of 30%. With the
exception of the first year of our study, the shedding rate
appeared to be steady at 20% to 30% over 2 years. A sim-
ilar shedding rate was found in a California study; 23% of
840 cattle were shedding C. burnetii in their milk (13).
Continual daily and weekly shedding in the milk by the
infected cattle suggests chronic infection by C. burnetii.
Chronic C. burnetii infection of dairy cattle could be the
most important source of human infection simply based on
sheer numbers (1). Extrapolation of our data to the nation-
al dairy herd suggests that nearly 3 million lactating cattle
are shedding C. burnetti daily. Though the mode and
extent of transmission from bovine to human has not been
determined, epidemiologic studies indicate that Q fever
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Figure. Agarose gel electrophoresis of Coxiella burnetii Trans-
polymerase chain reaction products amplified from total DNA of
bulk tank milk samples. Lanes 1 to 20, bulk tank milk samples; N,
water negative control; P, positive control (DNA of Nine Mile
strain). The arrow indicates the amplification of a 687-bp fragment
in the IS1111 sequence of C. burnetii.develops in farmers, veterinarians, and slaughterhouse
workers who are in contact with domestic animals (14).
While infection from commercial milk is unlikely because
of the pasteurization process, ingestion of raw milk has
been linked to higher seroprevalence rates.
In the aftermath of September 11, 2001, and the anthrax
incidents, the use of biologic warfare is no longer a distant
possibility. C. burnetii is considered a potential bioterror-
ism agent because of its high infectivity (a single organism
may cause disease in human), its ease of dispersion in
aerosols (because of its small, sporelike structure), and its
resistance to extreme environmental conditions and chem-
icals (15). Therefore, further investigations are needed to
determine the implications of the high prevalence of C.
burnetii in dairy herds, to address the potential risk to pub-
lic health, and to be prepared for outbreaks and bioterror-
ism events. Currently, no commercial vaccines are
available for cattle, and no effective treatment protocol
exists for infected animals.
Dr. Sung Guk Kim is director of molecular diagnostic sec-
tion at the Animal Health Diagnostic Laboratory, College of
Veterinary Medicine, Cornell University. He is interested in
infectious animal diseases and zoonoses. 
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